HIV Counseling Intervention for Methadone-Maintained Patients - 2

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.

The purpose of this proposal is to evaluate, in methadone-maintained patients the association between an ADHD diagnosis and high-risk HIV/Hepatitis behavior. In addition, the investigators would like to determine whether a new manually-guided HIV intervention; RISE: Reduce high risk Intravenous drug use and unsafe Sexual Encounters is superior to standard HIV/Hepatitis psycho-education.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:

18 Years to 60 Years (Adult)

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

No

Criteria

Inclusion Criteria:

Must meet DSM-IV criteria for opiate dependence and currently in methadone maintenance treatment

Able to give informed consent and capable of complying with study procedures

Women who are of childbearing age and/or pregnant may be included

Individuals who are HIV-positive or have Acquired Immunodeficiency Syndrome may be included

Patients who demonstrate moderate to high HIV risk behaviors will be included

Patients with low to no HIV risk behaviors will be excluded

Patients receiving a stable dose of methadone for three weeks will be included